A
Antonio Martinez
Researcher at University of Barcelona
Publications - 80
Citations - 5193
Antonio Martinez is an academic researcher from University of Barcelona. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 32, co-authored 77 publications receiving 4698 citations. Previous affiliations of Antonio Martinez include University of Perugia & Sofia University.
Papers
More filters
Journal ArticleDOI
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.
Joaquim Carreras,Armando López-Guillermo,Armando López-Guillermo,Bridget C. Fox,Bridget C. Fox,Lluis Colomo,Lluis Colomo,Antonio Martinez,Antonio Martinez,Giovanna Roncador,Giovanna Roncador,Emili Montserrat,Emili Montserrat,Elias Campo,Elias Campo,Alison H. Banham,Alison H. Banham +16 more
TL;DR: In conclusion, high Treg numbers predict improved survival of follicular lymphoma patients, while a marked reduction in Tregs is observed on transformation to DLBCL.
Journal ArticleDOI
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Sílvia Beà,Rafael Valdés-Mas,Alba Navarro,Itziar Salaverria,David Martín-García,Pedro Jares,Eva Giné,Magda Pinyol,Cristina Royo,Ferran Nadeu,Laura Conde,Manel Juan,Guillem Clot,Pedro Vizán,Luciano Di Croce,Diana A. Puente,Mónica López-Guerra,Alexandra Moros,Gaël Roué,Marta Aymerich,Neus Villamor,Lluis Colomo,Antonio Martinez,Alexandra Valera,José I. Martín-Subero,Virginia Amador,Luis Hernández,María Rozman,Anna Enjuanes,Pilar Forcada,Ana Muntañola,Elena Hartmann,María José Calasanz,Andreas Rosenwald,German Ott,Jesús M. Hernández-Rivas,Wolfram Klapper,Reiner Siebert,Adrian Wiestner,Wyndham H. Wilson,Dolors Colomer,Armando López-Guillermo,Carlos López-Otín,Xose S. Puente,Elias Campo +44 more
TL;DR: This study identifies molecular mechanisms contributing to MCL pathogenesis and offers potential targets for therapeutic intervention.
Journal ArticleDOI
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
Javeed Iqbal,George E. Wright,Chao Wang,Andreas Rosenwald,Randy D. Gascoyne,Dennis D. Weisenburger,Timothy C. Greiner,Lynette M. Smith,Shuangping Guo,Ryan A. Wilcox,Bin Tean Teh,Soon Thye Lim,Soon Yong Tan,Lisa M. Rimsza,Elaine S. Jaffe,Elias Campo,Antonio Martinez,Jan Delabie,Rita M. Braziel,James R. Cook,Raymond R. Tubbs,German Ott,Eva Geissinger,Philippe Gaulard,Pier Paolo Piccaluga,Stefano Pileri,Wing Yan Au,Shigeo Nakamura,Masao Seto,Françoise Berger,Laurence de Leval,Joseph M. Connors,James O. Armitage,Julie M. Vose,Wing C. Chan,Louis M. Staudt +35 more
TL;DR: Gene-expression profiles, immunohistochemistry, and IDH2 mutation analysis in reclassified cases supported the validity of the reclassification of PTCL-NOS cases, and high expression of several signatures associated with the tumor microenvironment was significantly associated with outcome.
Journal ArticleDOI
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
Lluis Colomo,Armando López-Guillermo,Armando López-Guillermo,María Perales,María Perales,Susana Rives,Susana Rives,Antonio Martinez,Antonio Martinez,Francesc Bosch,Francesc Bosch,Dolors Colomer,Dolors Colomer,Brunangelo Falini,Brunangelo Falini,Emili Montserrat,Emili Montserrat,Elias Campo,Elias Campo +18 more
TL;DR: In conclusion, differentiation profile was associated with particular clinicopathological features but was not essential to predicting outcome in DLBCL patients.
Journal ArticleDOI
Gene expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Gonzalo Gutiérrez-García,Teresa Cardesa-Salzmann,Fina Climent,Eva González-Barca,Santiago Mercadal,Jose Luis Mate,Juan M. Sancho,Leonor Arenillas,Sergi Serrano,Lourdes Escoda,Salomé Martínez,Alexandra Valera,Antonio Martinez,Pedro Jares,M. Pinyol,Adriana García-Herrera,Alejandra Martínez-Trillos,Eva Giné,Neus Villamor,Elias Campo,Luis Colomo,Armando López-Guillermo +21 more
TL;DR: In this article, the authors constructed tissue microarrays with 157 DLBCL patients homogeneously treated with immunochemotherapy to apply the following immunostaining algorithms: Colomo (MUM1/IRF4, CD10, and BCL6 antigens), Hans (CD10, BCL 6, and MUM 1/ IRF4 plus BCL2), Muris (CD 10 and MCI 1, MCI 2), Choi (GCET1, MUM 3, MCIA 4, CD 10, NCI 3, and NCI 4